Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis.

Maria Gaurnizo-OrtizLauren D Nephew Eduardo Vilar-GomezCarla D KettlerJames E SlavenMarwan S GhabrilArchita P DesaiEric S OrmanNaga ChalasaniSamer Gawrieh Kavish R Patidar

Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)

mAH carries a 12% mortality rate at 90 days. Age, AKI and corticosteroid use were associated with an increased risk for 90-day mortality. Avoidance of corticosteroids and strategies to reduce the risk of AKI could improve outcomes in mAH patients.

Keyphrases

acute kidney injury
end stage renal disease
cardiovascular events
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
prognostic factors
cardiovascular disease
high intensity
metabolic syndrome
patient reported outcomes
skeletal muscle